VC-backed Repare Therapeutics goes public, raises $220m
Repare Therapeutics, a Boston- and Montreal-based precision oncology company, has raised about US$220 million for its IPO after pricing its 11 million shares at US$20 per share.
19 June 2020•3 mins read
